5
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 331-340 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Betacell: a microencapsulated nuclear battery. DIVERS, E. F.-II I., Proc. Intersoc Energy Conyers. Eng. Conf., (1994): 29th (Pt. 3), 1442–7.
  • Quantitative determination of arteannuin in liposomes and dextrans by TLC-scanning method. CAI, M., Zhongcaoyao, 1994, 25, (7), 353–4. 376.
  • The influence of terminal gamma-sterilization on captopril containing poly(DL-lactide-co-glycolide) microspheres. VOLLAND, C., WOLFF, M., and KISSEL, T.J. Controlled Release, 1994, 31, (3), 293–305.
  • The complement- but not mannose receptor-mediated phagocytosis is involved in the hepatic uptake of cetyl mannoside-modified liposomes in situ. MATSU°, H., FUNATO, K., HARASHIMA, H., and KIWADA, H., J. Drug Targeting, 1994, 2, (2), 141–6.
  • Drugs-in-cyclodextrins-in liposomes: a novel concept in drug delivery. MCCORMACK, B., and GREGORIADIS, G., Int. y. Pharm., 1994, 112, (3), 249–258.
  • Preparation and dissolution characteristics of albumin microspheres containing betamethasone sodium phosphate. CHO. Y. Y., and Ku, Y. S., Nonchong-Han'guk Saenghwal Kwahak Yonguwon, 1993, 51, 151–160.
  • Controlled release microspheres of diclofenac sodium prepared by spherical crystallization technique. GUPTA, V. K., JAYSAWAL, S. B., SRIVASTAVA, A. K., and KUMAR, M. V., Pharmazie, 1994, 49, (9), 692–693.
  • Preparation and in vitro evaluation of streptomycin sulfate loaded albumin microspheres for lung targeting. KUMAR, M. V., JAYASWAL, S. B., GUPTA, and VISHAL, K., Pharmazie, 1994, 49, (9), 691–692.
  • Prostaglandin and tumor necrosis factor secretion by peritoneal macrophages isolated from normal and arthritic rats treated with liposomal methotrexate. WILLIAMS, A. S., CAMILLEREI, J. P., TOPLEY, N., and WILLIAMS, B. D., y. Pharmacol. Toxicol. Methods, 1994, 32, (1), 53–58.
  • Polyethylene glycol on the liposome surface: on the mechanism of polymer-coated liposome longevity. TORCHILIN, V. P., OMELYANENKO, V. G., PAPISOV, M. 1., BOGDANOV, A. JR., TRUBETSKOY, V. S., HERRON, J. N., and GENTRY, C. A., Biochim. Biophys. Acta, 1994, 1195, (1), 11–20.
  • New amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes. WOODLE, M. C., ENGBERS, C. M., and ZALIPSKY, S., Bioconjugate Chem., 1994, 5, (6), 493–496.
  • Precision and accuracy of analysis of air-filled albumin microspheres using Coulter Multisizer Mark H. SONTUM, P. C., and CHRISTIANSEN, C., J. Pharm. Biomed. Anal., 1994, 12, (10), 1233–1241.
  • Membrane modification by negatively charged stearylpolyoxyethylene derivatives for thermosensitive liposomes: reduced liposomal aggregation and avoidance of reticuloendothelial system uptake. IGA, K., OHKOUCHI, K., OGAWA, Y., and TOGUCHI, H., J. Drug Targeting, 1994, 2, (3), 259–267.
  • In vitro and in vivo antifungal activity of liposomal and free itraconazole against Candida albicans. LE CONTE, P., FAINTRENY, A., POTEL, G., LEGALLOU, F., BUGNON, D., and BARON, D., Curr. Ther. Res., 1994, 55, (8), 938–943.
  • Pharmacokinetics of levonorgestrel after a single dose of biodegradable microspheres containing levonorgestrel in rats. ZHANG, L. C., SANG, G. W., and SHAO, Q. X., Yaouxue Xuebao, 1994, 29, (8), 561–566.
  • Thermal insulation mechanism of hollow microsphere light weight bricks. XI AO, J., Kuangwu Xuebao, 1994, 14, (1), 92–97.
  • The preparation of microcapsules which include silicon carbide particles in a wall material. KIMURA, 1., SOUMA, A., SAITO, N., and TANAKA, M., Funtai Kogaku Kaishi, 1994, 31,(1), 10–17.
  • Microstructure and fat extractability in microcapsules based on whey proteins or mixtures of whey proteins and lactose. MOREAU, D. L., and ROSENBERG, M., Food Struct., 1993, 12, (4), 457–468.
  • Secretion of beta-thromboglobulin and serotonin from human platelets induced by microbubbles differs from secretion induced by collagen and polystyrene microspheres. STAIN, M. R., THORSEN, T., NORDVIK, A., and HOLMSEN, H., Platelets, 1994, 5, (4), 209–213.
  • Interaction of radiolabeled Na, K-ATPase-liposomes with human peripheral blood mononu-clear cells. ANNER, B. M., MENEGHINI, E., HUSSAIN, S., LACOTTE, D., and MooKmAYEK, M., Biochim. Biophys. Acta, 1994, 1194, (2), 345–348.
  • Adsorption of proteins on polystyrene microspheres and development of latex agglutination test. GRITSKOVA, A., Miss, P. V., DOROKHOVA, E. A., GUSEV, S. A., KRASHENINNIKOVA, I. G., and AL, D. I., Kolloidn Zh., 1994, 56, (4), 491–495.
  • Absorption flattening in the optical spectra of liposome-entrapped substances. WITTUNG, P. KAJANUS, J., KUBISTA, M., and MALMSTROEM, B. G., FEBS Lett., 1994, 352, (1), 37–40.
  • Polyethyleneglycol- and metal ion-induced fusion of liposomes and cells. YANG, J., CAO, H., and LIN, Q., Shengwu Huaxue Yu Shengwu Wuli Xuebao, 1994, 26, (3), 257–262.
  • A new method to measure bilayer thickness: Cryo-electron microscopy of frozen hydrated liposomes and image simulation. TAHARA, Y., and FUJIYOSHI, Y., Micron., 1994, 25, (2), 141–149.
  • Preparation of cross-linked transferrin-liposomes with potential targeting activity. YANG, J., WANG, D., and LIN, Q., Shengwu Huaxue Yu Shengwu Wuli Xuebao, 1994, 26, (3), 327–331.
  • Immunoassay with microspheres. MATSUZAWA, S., juntendo Igaku, 1994, 40, (2), 137–152.
  • Polymer materials for bionanalysis and bioseparation. 5.1. Microspheres for diagnosis and bioseparation. KAWAGUCHI, H., Biomed. Appl. Polym. Mater., CRC, Boca Raton, Fla, 1993, 299–324.
  • New approaches in the chemical design of Gd-containing liposomes for use in magnetic resonance imaging of lymph nodes. TRUBETSKOY, V. S., and Milo-HUN, V. P., J. Liposome Res., 1994, 4, (2), 961–980.
  • Liposomes for liver scintigraphy. KHAR, R. K., and JAGGI, M.,y. Liposome Res., 1994,4, (2), 939–957.
  • Tissue distribution of 99mTc-labeled liposomes prepared from synthetic amphiphiles containing amino acid residues. GOTO, R., 7. Liposome Res., 1994, 4, (2), 877–905.
  • Liposomal delivery of boron to murine tumors for boron neutron capture therapy. FEAKF:S, D. A., SHELLY, K. J., HAWTHORNE, M. F., SCHMIDT, P. G., ELSTAD, C. A., MEADOWS, G. G., and BALER, W. F., Adv. Neutron Capture Ther., (Proc. Int. Symp.), 5th, Plenum, New York, 1993, 395–8.
  • Mechanisms of liposomal contrast agents in magnetic resonance imaging. PUTZ, B., BARSKY, D., and SCHULTEN, K., 7. Liposome Res., 1994, 4, (2), 771–808.
  • Use of Intelimer microcapsules to control the release of agricultural products and reduce leaching. MEYERS, P. A. GREENE, C. L., and SPRINGER, J. T., ASTM Spec. Tech. Publ., 1993, STP 1183, (Pesticide Formulations and Application Systems: 13th Volume), 335–347.
  • Introduction of hepatitis delta virus into animal cell lines via cationic liposomes. BICHKO, V., NETTER, H. J., and TAYLOR, J., 1994, 68, (8), 5257–5252.
  • Further studies on SA liposome mediated transfection. YANG, J., KONG, Y., and LIN, Q., Shengwu Huaxue Yu Shengwu Wuli Xuebao, 1994, 26, (2), 123–128.
  • Cholesterol limits estrogen uptake by liposomes and erythrocyte membranes. JAcoasotiN, M. K., BALDER, S., PINE, S. R., and JACOBSOHN, G. M., Biochim. Biophys. Acta, 1994, 1195, (1), 131–140.
  • A23187 releases bound rather than free calcium from calcium-loaded liposomes. CLACK, J. W., BROWN, P. S., FELDMANN, J. M., and WITZMANN, F. A., Biochem. Biophys. Res. Commun., 1994, 204, (1), 142–149.
  • Prolonged analgesia with liposomal bupivacaine in a mouse model. GRANT, G. J., VERNIEULEN, K., LANGERMAN, L., ZAKOWSKI, M., and TURNDORF, H., Reg. Anesth., 1994, 19, (4), 264–269.
  • Lipidheme-microsphere (LH-M) a new type of totally synthetic oxygen carrier and its oxygen carrying ability. KAKIZAKI, T., KOBAYASHI, K., KOMATSU, T., NtstuDE, H., and TSUCHIDA, E., Artif. Cells, Blood Substitutes, Immobilization Biotechnol., 1994, 22, (3), 933–938.
  • Indefinite graft survival of discordant islet xenografts in the NOD mouse with agarose microencapsulation and 15-deoxyspergualin. AOMATSU, Y NAKAJIMA, Y., IWATA, H., TAKAGI, T., AMEMIYA, H., KANEHIRO, H., HISENAGA, M., FUKUOKA, T., YOSHIMURA, A., etal. Transplant Proc., 1994, 26, (2), 805–806.
  • Experimental study on treatment with local hyperthermia and temperature-sensitive liposomes containing adriamycin. HORIBE, T., SANDA, J., MizuGucHI, Y., M IZUMURA, Y., NiKI, S., IDE, M., ONODA, K., MIWA, K., OHNO, H., etal. Tokyo Ika Daigaku Zasshi, 1994, 52, (4), 458–467.
  • Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. MING, S., MACLEOD, K., ABFtA, R. M., HUANG, A. H., and HAHN, G. M., Int. 7. Radial. Oncol. Biol. Phys., 1994, 29, (4), 827–834.
  • A study on the anticancerous mechanism of linoleic acid polyphase liposome of liquid crystalline state by means of SAXS and 31P-NMR. SUN, R., WANG, D., DAI, Z., WANG, Z., and ZHANG, J., Chin. Sci. Bull., 1993, 38, (17), 1437–1442.
  • Combined liposome-encapsulated muramyl tripeptide and cisplatin in dogs with osteosar-coma. MACEWEN, E. G., KURZMAN, I. D., ROSENTHAL, R. C., Fox, L., and MADEWELL, B. R., Front Osteosarcoma Res., 1993, 117–119.
  • Binding of biotinated-liposomes to streptavidin is influenced by liposome composition. CORLEY, P., and LOUGHREY, H. C., Biochim. Biophys. Acta, 1994, 1195, (1), 149–156.
  • Circulation profile of technetium-99m labeled liposome encapsulated hemoglobin in a 10% or 50% rat hypovolemic shock model. GOINS, B., KLIPPER, R., SANDERS, J., RUDOLPH, A. S., and PHILLIPS, W. T., Arti f. Cells, Blood Substitutes, Immobilization Biotechnol., 1994, 22, (3), 909–915.
  • Study of Nd-glass microsphere spectra modified by cavity QED effect. Lu, B., WANG, Y., Li, Y., and Liu, Y., Guangxue Xuebao, 1994, 14, (3), 253–256.
  • Controlled-release systems for proteins based on gelatin microspheres. RAO, J. K., RAMESH, V., and RAO, K. P., J. Biomater. Sci. Polym. Ed., 1994, 6, (5), 391–398.
  • Non-specific modulation of the immune response with liposomal meningococcal lipopolysac-charide: role of different cells and cytokines. PETROV, A., B., KOLENKO, V. M., KOSHKINA, N. V., ZAKIROV, M. M., BUGAEV, L. V., SEMENOVA, I. B., WIERTZ, E. J. H. J., and POOLMAN, aJ. T., Vaccine, 12, (12), 1064-1070.
  • Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid. MEHTA, K., SADEGHI, T., MCQUEEN, T., and LOPEZ, B. G., Leuk. Res., 1994, 18, (8), 587–596.
  • Microencapsulation of chlorpheniramine maleate, a drug with intermediate solubility properties, by a non-aqueous solvent evaporation technique. BODMEIER, R., WANG, H., and HERRmANN, J., STP Pharma. Sci., 1994, 4, 275–281.
  • Preparation and evaluation of crosslinked chitosan microspheres containing furosemide. AKBUGA, J., and DURNIAZ, G., Int. J. Pharm., 1994, 111, (3), 217–222.
  • Therapeutic effect of adriamycin encapsulated in long-circulating liposomes on Meth-A sarcoma-bearing mice. OKu, N., Koi, K., NAMBA, Y., and OKADA, S., Int. y. Cancer, 1994, 58, (3), 415–419.
  • Palmitoylpolysaccharide-coated liposomes as a potential oral drug carrier. HAHN Y. H., Y1, J. W., and CHOI, Y. W., Yakche Hakhoechi, 1994, 24, (2), 72–82.
  • Large-scale production of liposomes containing monomeric zinc phthalocyanine by controlled dilution of organic solvents. SCHIWECK, K., and LEUENBERGER, H., y. Pharm. Sci., 1994, 83, (11), 1608–1616.
  • Liposomes sequestered in chitosan gel as a delivery device for dapsone. ALAMELU, S., and RAO, K. P., Carbohydr. Polym., 1994, 24, (3), 223–251.
  • pH-Independent controlled-release microspheres using polyglycerol esters of fatty acids. AKIYAMA. Y., YOSHIOKA, M., HORIBE, H., HIRAI, S., KITAMORI, N., and TOGUCHI, H., J. Pharm. Sci., 1994, 83, (110, 1600–1607.
  • High efficiency liposome-mediated transfection of the tyrosinase gene to cultured cells: A model for the gene therapy of hair color restoration. Li, L., HOFFMAN, R. M., and Li SHKO, V., In Vitro Cell. Dev. Biol. Anim., 1994, 30A, (3), 135–138.
  • Liposomes that provide T-dependent help to weak antigens (T-independent antigens). PIETROBON, P. J. F., GARCON, N., LEE, C. H., and Six, H. R., ImmunoMethods, 1994, 4, (3), 236–243.
  • Complex coacervation: microcapsule formation. BURGESS, D. J., Macromol. Complexes Chem. Biol., Springer, Berlin, Germany, 1994, 285–300.
  • Systematic targeting of liposome-encapsulated immunomodulators to macrophage for treatment of cancer metastasis. KILL0N, J. J., and Ft DLER, I., ImmunoMethods, 1994, 4, (3), 273–279.
  • Liposome-mediated cytoplasmic delivery of proteins: an effective means of accessing the MHC class l-restricted antigen presentation pathway. ZHou, F., HUANG, L., ImmunoMethods, 1994, 4, (3), 229–235.
  • Endocytosis and presentation of liposome-associated antigens by B cells. GRIVEL, J. C., CROOK, K., and LESERMAN, L., ImmunoMethods, 1994, 4, (3), 223–228.
  • Liposomes as carriers for vaccines. WASSEF, N. M., ALVING, C. R., and RICHARDS, R. L., ImmunoMethods, 1994, 4, (3), 217–222.
  • Liposomes as immunoadjuvants and vaccine carriers: antigen entrapment. GREGORIADIS, G., ImmunoMethods, 1994, 4, (3), 210–216.
  • Liposomes for protein delivery: selecting manufacture and development processes. WEINER, A., ImmunoMethods, 1994, 4, (3), 201–209.
  • Stimuli-sensitive microcapsules. MAKINO, K., Pharm. Tech. Jpn., 1994, 10, (8), 913–920.
  • Polyanhydride microspheres as drug delivery systems. MATHIOWITZ, E., and LANGER, R., Microcapsules Nanopart Med. Pharm., CRC, Boca Raton, Fla, 1992, 99–123.
  • Microsphere-filled lightweight calcium phosphate cements. SUGAMA, T., and WETZEL, E., I. Mater. Sci., 1994, 29, (19), 5165–5176.
  • Application of ceramic ZnO microspheres as material with controlled-release function. KUBOTA, S., and ITO, O., Kenkyu Hokoku-Wakayama-ken Kogyo Gijutsu Senta, 1993, 10–12. 92.
  • Study on extraction of Cr2072- with microcapsules containing TOA. BA, G., WANG, Y SUN, W., Wu, Z., and ZHANG, H., Huanjing Huaxue, 1994, 13, (4), 323–327.
  • Preparation of magnetic polymer microspheres and their characterization. Qiu, G., Z HANG, X., and SUN, Z., Gaofenzi Cailiao Kexue Yu Gongcheng, 1993, 9, (2), 38–43.
  • Synthesis of magnetic polymer microspheres by dispersion polymerization. Qiu, G., and SUN, Z., Gongneng Gaofenzi Xuebao, 1993, 6, (2), 123–130.
  • Dynamics of radical scavenging by .alpha.-tocopherol and its recycling by ascorbic acid in liposomes. FUKUZAWA, K., Bitamin., 1994, 68, (5-6), 263–274.
  • Interaction between ganglioside-containing liposome and rat T-lymphocyte: confocal fluorescence microscopic study. KATO, E., AKIYOSHI, K., FURUNO, T., NAKANISHI, M., KIKUCHI, A., KATOKA, K., and SUNAMOTO, J., Biochem. Biophys. Res. Commun., 1994, 203, (3), 1750–1755.
  • Liposome-mediated DNA transfer into chicken primordial germ cells in vivo. WATANABE, M., NAITO, M., SASAKI, E., SAKURAI, M., KUWANA, T., and OISHI, T., Mol. Reprod. Dev., 1994, 38, (3), 268–274.
  • Preparation and experimental method of liposomes. OKU, N., (Hirokawa Publishing Co., Tokyo, Japan), 128 pp.
  • Preparation of liposomes using instantaneous vacuum-dried lipid mixture. SAKAKIBARA, T., and NAMBA, Y Yukagaku, 1994, 43, (9), 729–732.
  • Transfer of membrane proteins from human platelets to liposomal fraction of interaction with liposomes containing an artificial boundary lipid. OKUMURA, Y., ISHITOBI, M., SOBEL, M., AKIYOSHI, K., and SUNAMOTO, J., Biochim. Biophys. Acta, 1994, 1194, (2), 335–340.
  • The low-frequency dielectric response of liposomes. BARKER, S. A., CRAIG, D. Q. M., HILL, R. M., and TAYLOR, K. M. G., J. Colloid. Interface Sci., 1994, 166, (1), 66–67.
  • Effect of microwave radiation on permeability of liposomes. Evidence against nonthermal leakage. BERGQVIST, B., ARVIDSSON, L., PETTERSSON, E., GALT, S., SAALMAN, E., HAMNERICS, Y., and NORDEN, B., Biochim. Biophys. Acta, 1994, 1201, (1), 51–54.
  • Effect of microwave radiation on the permeability of carbonic anhydrase loaded unilamellar liposomes. ORLANDO, A. R., MOSSA, G. D., and I NZEO, G., Bioelectromagnetics (NY), 1994 15, (4), 303–313.
  • Liposomal blood pool agents for nuclear medicine and magnetic resonance imaging. TiLCOCK, C., J. Liposome Res., 1994, 4, (2), 909–936.
  • Stability and proton-permeability of liposomes composed of archaeal tetraether lipids. ELFERINK, M. G. L., DE WIT, J. G., DRIESSEN A. J. M., and KONINGS, W. N., Biochim. Biophys. Acta, 1994, 1193, (2), 247–254.
  • The use of liposomes in the investigation of mechanisms of asbestos damage. ERDOGDU, G., and HASIRCI, V. N., Experientia, 1994, 50, (8), 785–778.
  • A quantitative assay for trans-activation by HIV-1 Tat, using liposome-mediated DNA uptake and a parallel ELISA system. WATSON, M. E. E., and MOORE, M., AIDS Res. Hum. Retroviruses, 1993, 9, (9), 861–867.
  • Suppression of acute inflammation with liposome associated prostaglandin El. ROSSETTI, R. G., BRATHWAITE, K., and ZURIER, R. B., Prostaglandins, 1994, 48, (3), 187–195.
  • No lung toxicity after repeated aerosol or intravenous delivery of plasmid-cationic liposome complexes. CONONICO, A. E., PLITMAN, J. D., CONARY, J. T., MEYRICK, B. O., and BRIGHAM, K. L., J. Appl. Physiol., 1994, 77, (1), 415–419.
  • Protective effect of liposome-encapsulated SOD on acute gastric mucosal lesions in rats induced by diethyldithiocarbamate. Wu. L., and DENG, C., Zhongguo Bingli Shengli Zazhi, 1994, 10, (3), 302–305.
  • Daunomycin-human albumin microspheres (Dau-HA-MS)-preparation, characterization and use in experimental cancer therapy. WANG, R., ZHONG, W., and GUAN, S., Zhonghua Zhongliu Zazhi, 1994, 16, (2), 98–101.
  • Tissue distribution and cellular distribution of liposomes encapsulating muramyltripeptide phosphatidyl enthanolamide: tissue and cellular distribution of LE-MTPPE. MELISSEN, P.M. B., VAN VIANEN, W., LEENEN, P. J. M., and BAKKER, W. I. A. J. M., Biotherapy (Dordrecht, Neth), 1993, 7, (1), 71–87.
  • Fluorometric determination in biological fluids of the release kinetics of liposome-entrapped doxorubicin. FREZARD, F., 1. Liposome Res., 1994, 4, (2), 1063–1073.
  • Analyis of resonant structures in the spectrum of a Nd-glass microsphere. Lu, B., WANG, Y., Li, Y., and Liu, Y., Zhongguo jiguang, 1994, A21, (3), 207–210.
  • Large-scale production of liposomes of defined size by a new continuous high pressure extrusion device. SCHNEIDER, T., SACHSE, A., ROESSLING, G., and BRANDL, M., Drug Dev. Ind. Pharm., 1994, 20, (18), 2787–2807.
  • Preparation and characterization of ethyl cellulose microspheres containing 5-fluorouracil. ZINUTTI, C., KEDZIEREWICZ, F., HOFF-MAN, M., and MAINCENT, P., y. microencapsulation, 1994, 11, (5), 555–563.
  • Preparation, characterization and biodistribution of a mixed 1311-hippuran loaded liposome system. SAWAS, D. C., PANAGI, Z., ITHAKISSIOS, D., and PALEOS, C. M., Prog. Colloid. Polym. Sci., 1993, 93, (Trends in Colloid and Interface Science VII), 330–332.
  • Biodegradable microspheres: a new delivery system for growth hormone. Di SiLvio, L., GURAV, N., KAYSER, M. V., BRADEN, M., and DOWNES, S., Biomaterials, 1994, 15,(11), 931–936.
  • Radical methyl methacrylate-methacrylic acid copolymerization in isopropyl alcohol, acetone, and their mixtures. Application of the copolymer products for microencapsu-lation of ampicillin trihydrate. GEORGIEV, G. S., DAKOVA, I. G., and VALOVA, N. L., Colloid. Polym. Sci., 1994, 272, (8), 938–945.
  • Kinetics of bromocriptine release from microspheres: comparative analysis between different in vitro models. NASTRUZZI, C., ESPOSITO, E., CORTESI, R., GAMBARI, R., and MENEGATTI, E., Microencapsulation, 1994, 11, (5), 565–574.
  • Studies on the properties of ethyl cellulose microcapsules prepared by emulsion non-solvent addition method in the presence of non-solvent in polymer solution. Wu, J. C., CHEN, H. Y., and CHEN, H.,.7. Microencapsulation, 1994, 11, (5), 519–529.
  • Evaluation of the properties of ethyl cellulose-cellulose triacetate microcapsules containing theophylline prepared by different microencapsulation techniques. Wu, J. C., JEAN, W. J., and CHEN, H., y. Microencapsulation, 1994, 11, (5), 507–518.
  • Delivery of cytokines by liposomes. I. Preparation and characterization of interleukin-2 encapsulated in long-circulating sterically stabilized liposomes. KEDAR, E., RUTKOWSKI, Y., BRAUN, E., EMANUEL, N., BARENHOLZ, Y., y. Immunother. Emphasis Tumor Immunol., 1994, 16, (1), 47–59.
  • Fluorinated phosphatidylcholine-based liposomes: H+ /Na + permeability, active doxorubicin encapsulation and stability in human serum. FREZARD, F., SANTAELLA, C., MONTISCI, M. J., VIERI,ING, P., and RIESS, J. G., Biochim. Biophys. Acta, 1994, 1194, (1), 61–68.
  • Release rate and biodegradation of PLGA microspheres containing LNG in vivo. HAN, J., LIN F., and SHEN, W., Shengzhi Yu Biyun, 1994, 14, (3), 188–192.
  • Phosphatidyl polyglycerols prolong liposome circulation in vivo. MARUYANIA, K., OKUIZUMI, S., ISHIDA, O., YANIAUCHI, H., KIKUCHI, H., and IWATSURU, M., Int. y. Pharm., 1994, 111,103–107.
  • Liposome-entrapped antioxidant enzyme delivery to the alveoli of the lung. CZOPF, L., BAKER, R. R., JILLING, T., FREEMAN, B. A., KIRK, K. L., and MATALON, S., Oxygen Free Radicals Scavengers Nat. Sci., Pap. Participants Congr., Akad. Kiado, Budapest, Hung., 1993, 135–41.
  • Two types of totally artificial red blood cell substitutes, liposome embedded heme(L/H) and lipid-heme/microsphere (LHM). KOBAYASHI, K., KAKIZAKI, T., KOMATSU, T., NISHIDE, H., and TSUCHIDA, E., Artif. Cells, Blood Substitutes, Immobilization Biotechnol., 1994, 22, (3), 895–900.
  • Preparation and characterization of poly(lactic acid) hemoglobin microspheres. CEDRATI, N., MAINCENT, P., TuomAs, F., LABRUDE, P., and VIGNERON, C., Artif. Cells, Blood Substitutes, Immobilization Biotechnol., 1994, 22, (3), 867–873.
  • Structure and solution properties of lipidheme-microsphere. KOMATSU, T., NISHIDE, H., and Tsuctil DA, E., Artif. Cells, Blood Substitutes, Immobilization Biotechnol., 1994, 22, (3), 855–860.
  • Influence of the structure of support microspheres on leukocyte activation by RGDS-carrying microspheres. KASUYA, Y., FujimoTo, K., KAWAGUCHI, H., and MIYAMOTO, M., Biomaterials, 1994, 15, (8), 570–576.
  • Stealth liposomes-an overview. SRINATH, P., and DIWAN, P. V., Indian y. Pharmacol., 1994, 26, (3), 179–184.
  • Liposomes: physicochemical properties and preparation. OZDEN, M. Y., and HASIRCI, V. N., Biyokim. Derg., 1993, 18, (3), 103–123.
  • Evaluation of drug-containing microscapsules. DEASY, P. B.J. Microencapsulation, 1994, 11, (5), 487–505.
  • Recent advances in artificial cells with emphasis on biotechnological and medical approaches based on microencapsulation. CHANG, T. M. S., Microcapsules Nanopart Med. Pharm. CRC, Boca Raton, Ha., 1992, 323–339.
  • Microencapsulation of living cells and tissues. SUN, A. M., VACEK, I., and TAI, I., Microcapsules Nanopart Med. Pharm., CRC, Boca Raton, Fla, 1992, 315–322.
  • Active targeting of microcapsules and microspheres to specific region. WRIGHT, J., and ILI,UM, L., Microcapsules Nanopart Med. Pharm., CRC, Boca Raton, Fla., 281–297.
  • Chemo-embolization and passive targeting with degradable starch microspheres. EDNIAN, P., and SJOEHOLM, I., Microcapsules Nanopart Med. Pharm., CRC, Boca Raton, Fla., 265–280.
  • Clinical uses of microcapsules and microspheres. JUNI, K., and NAKANO, M., Microcapsules Nanopart Med. Pharm., CRC, Boca Raton, Fla, 1992, 257–264.
  • Pharmacokinetic considerations related to bioavailability of sustained-release microencapsu-lated drugs for oral use-assessment of absorption rates. GOTO, S., and UCHIDA, T., Microcapsules Nanopart med. Pharm., CRC, Boca Raton, Fla., 1992, 239–253.
  • The relation of release profiles from ensembles to those of individual microcapsules and the influence of types of batch heterogeneity on release kinetics. DONBRON, M., Microcapsules Nanopart Med. Pharm., CRC, Boca Raton, Fla, 1992, 219–237.
  • In vitro release from microcapsules and microspheres. JALSENJAK, I., Microcapsules Nanopart Med. Pharm., CRC, Boca Raton, Fla, 1992, 193–218.
  • Recent advances in microencapsulation of drugs to obtain reduced gastric irritation. BAKAM, J. A., POWELL, T. C., and SZOTAK, P. S., Microcapsules Nanopart Med. Pharm., CRC, Boca Raton, Fla, 1992, 183–192.
  • Interaction of microcapsules with blood components. KONDO, T., Microcapsules Nanopart Med. Pharm., CRC, Boca Raton, Fla., 1992, 167–181.
  • Gastrointestinal transit of microcapsules. FELL, J. T., Microcapsules Nanopart Med. Pharm., CRC, Boca Raton, Fla, 1992, 159–165.
  • Recent advances using microencapsulation for taste-masking of bitter drugs. BAKAN, J. A., POWELL, T. C., and SZOTAK, P. S., Microcapsules Nanopart Med. Pharm., CRC, Boca Raton, Fla, 1992, 149–156.
  • Developments in phase methods, aggregation control, and mechanisms of microencapsulation. DONBROW, M., Microcapsules Nanopart Med. Pharm., CRC, Boca Raton, Fla, 1992, 17–45.
  • Liposomes as antigen delivery systems in viral immunity. REDDY, R., NAIR, S., BRYNESTAD, K., and ROUSE, B. T., Semin. Immunol., 1992, 4, (2), 91–96.
  • Hydrocarbon dispersions of acrylic microspheres with polar surface functionality. LEE, K. C., WINNIK, M. A., and JA0, T.C.J. Polym. Sci. Part A: Polym. Chem., 1994, 32, (12), 2333–2344.
  • Fluorescence analysis of ANS interacting with individual laser-trapped microspheres having different surface properties. PFEIFER, F. Y., MISWAWA, H., FUKUMURA, H., and MASUHARA, H., Chem. Lett. (9), 1994, 1589–1592.
  • Liposome stabilized retinal Schiff bases. DAs, J., and SINGH, A. K., Indian 1. Chem. Sect. B: Org. Chem. Include. Med. Chem., 1994, 33B, (7), 615–617.
  • Sphingomyelin from milk—characterization of liquid crystalline, liposome and emulsion properties. MALMSTEN, M., BERGENSTAAHL, B., NYBERG, L., and ODHAM, G., J. Am. Oil Chem. Soc., 1994, 71, (9), 1021–1026.
  • Equilibrium and kinetic parameters for the interaction of a monoclonal antibody with liposomes bearing fluorescent haptens. PETROSSIAN, A., Cell Biophys., 1993, 23, (1-3), 111–137.
  • Selective induction of protection against influenza virus infection in mice by a lipid-peptide conjugate delivered in liposomes. FRIED, M., MULLER, S., BRIAND, J. P., PLACE, S., FERNANDES, I., FRISCH, B., SCHUBER, F., and VAN REGENMORTEL, M. H. V., Vaccine, 1994, 12, (9), 791–797.
  • Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. VAN ROOIJEN, N., and SANDERS, A., J. Immuno. Methods, 1994, 174, (1-2), 83–93.
  • Mixing rates can markedly affect the kinetics of peptide-induced leakage from liposomes. POLOZOV, I. V., POLOZOVA, A. I., ANANTHARAMAIAH, G. M., SEGREST, J. P., and EPAND, R. M., Biochem. Mol. Biol. Int., 1994, 33, (6), 1073–1079.
  • TLC—a rapid method for liposome characterization. BRAILOIU, E., SAILA, L., Hui ICHEZ, G., COSTULEANU, M., FILIPEANU, C. M., SLATINEAU, S., COTRUTZ, C., and BRANISTEANU, D. D., Biomed. Chromatogr., 1994, 8, (4), 193–195.
  • Photodynamic therapy of human bladder carcinoma cells in vitro with pH-sensitive liposomes as carriers for 9-acetoxy-tetra-n-propylporphycene. AICHER, A., MILLER, K., REICH, E., and HAUTMANN, R., Urol. Res., 194, 22, (1), 25–32.
  • Magnetically directed poly(lactic acid) 90Y-microspheres: novel agents for targeted intracav-itary radiotherapy. HAEFELI, U. O., SWEENEY, S. M., BERESFORD, B. A., Sim, E. H., and MACKLIS, R. M., J. Biomed. Mater. Res., 1994, 28, (8), 901–908.
  • A new liposome-bound Ge(IV)-phthalocyanine (CGP 55398) for photodynamic therapy of tumors: Preliminary studies. SEGALLA, A., RE, G., MILANESI, C., CAPRARO, H. G., SCHIEWECK, K., and IsELE, U., Proc. SPIE-Int. Soc. Opt. Eng., 2078, (Photodynamic therapy of cancer), 507–512.
  • A study on evaluation of CBF measurement based on microsphere model with N-isopropyl-p-(123Diodoamphetamine (IMP) and SPECT. Its correction with the value of PaCo2. ODANO, I., TAKAHASHI, N., OHKUBO, M., OHTAKI, H., NOGUCHI, E., HATANO, Y., YAMAZAKI, Y., and NISHIHAFtA, M., Kaku Igaku, 1994, 31, (3), 223–229.
  • Adsorption of a polycation on the surface of negatively charged liposomes. Effect of phase state of the lipid bilayer on the composition of polycation-liposome complex.
  • VAROSLAVOV, A. A., EFIMOVA, A. A. KuLRov, V. Y., and KABANOV, V. A., Vysokomol Soedin, Ser A Ser B, 1994, 36, (2), 264–270.
  • Influence of cholesterol and dicetylphosphate on the physical parameters of liposomes. BONDAR, O. P., VOZIAN, P. A., DANCHUK, S. D., KURLIAND, D. I., and KHOLODOVA, Y. D., Biofizika, 1994, 39, (2), 323–327.
  • Changes in the lipid dynamics of liposomal membranes induced by poly (ethylene glycol): free volume alterations revealed by inter- and intramolecular excimer-forming phospholipid analogs. LEHTONEN, J. Y. A., and KINNUNEN, P. J., Biophys. y., 1994, 66,(6), 1981–1990.
  • Interaction of a peptide corresponding to the amino terminus region of the S protein of hepatitis B virus with liposomes. RODRIGUEZ, C. I., GOMEZ, G. J., PETERSON, D. L., and GAVILANES, F., Biochem. Soc. Trans., 22, (3), 365S.
  • ATP synthesis catalyzed by the ATP synthase of Escherichia colt reconstituted into liposomes. FISCHER, S., ETZOLD, C., TURINA, P., DECKERS, H. G., ALTENDORF, K., and GRAEBER, P., Eur.J. Biochem., 1994,. 225, (1), 167–172.
  • Modeling degranulation with liposomes: effect of lipid composition on membrane fusion. BROCK, T. G., NAGAPRAKASH, K., MARGOLIS, D. I., and SMOLEN, J. E., .7. Membr. Biol., 1994, 141, (2), 139–148.
  • Fluoresence anisotropy and light-scattering studies of the interaction of insulin with liposomes. SIKUROVA, L., and KRIS'FEKOVA, My. Fluoresc., 1993, 3, (4), 215–217.
  • Effects of naftidrofuryl oxalate on microsphere-induced changes in acetylcholine and amino acid content of rat brain regions. TAGUCHI, T., TAKAGI, N., MIYAKE, K., TANONAKA, K., OKADA, M., KAJIHARA, H., and TAKEO, S., Exp. Brain Res., 1994, 99, (1), 7–16.
  • Tissue protection after acute ischemia by transdermal drug administration with liposomes. ROESKEN, F., UHL, E., MENGER, M. D., CURRI, S. B., and MESSMER, K., Chir. Forum Exp. Klin. Forsch. 1993, 477–804.
  • Antioxidant profile of nimesulide, indomethacin, and diclofenac in phosphatidylcholine liposomes (PCL) as membrane model. MAFFEI, F. R., CARINI, M., ALDINI, G., SAIBENE, L., and MACCIOCCHI, A., Int. y. Tissue React., 1993, 15, (6), 225–234.
  • Cellular pharmacology of the partially non-cross-resistant anthracycline annamycin entrapped in liposomes in KB and KB-V1 cells. PEREZ, S. R., LING, Y. H., Zou, Y., and PRIEBE, W., Cancer Chemother. Pharmacol., 1994, 34, (2), 109–118.
  • Liposomal delivery of methylphosphonate antisense oligodeoxynucleotides in chronic myelogenous leukemia. TARI, A. M., TUCKER, S. D., DEISSEROTH, A., and LOPEZ, B. G., Blood, 1994, 84, (2), 601–607.
  • Liquid chromatography determination of liposome components using a light-scattering evaporative detector. JAEAESKELAEINEN, I., and URTTI, A., y. Pharm. Biomed. Anal., 1994, 12, (8), 977–982.
  • Determination of retinoic acid-liposomal association level in a topical formulation. BONTE, F., CHEVALIER, J. M., and MEYBECK, A., Drug Dev. Pharm., 1994, 20, (16), 2527–2534.
  • What is the better formulation of microencapsulated potassium chloride. SIMONEAU, G., BERGMANN, J. F., PAMPHILE, R., CAULIN, C., and SEGRESTAA, J. M., Eur. .7. Drug Metab. Pharmacokinet, 1994, 19, (1), 71–75.
  • Coating of pharmaceutical powders by fluidized bed process. VI. Microencapsulation using blend and composite latexes of copoly(ethyl acrylate-methyl methacrylate-2-hydroxyethyl methacrylate). ICHIKAVVA, H., TOKUMITSU, H., JoNo, K., FUKUDA, T., OSAKO, Y., and FUKUMORI, Y., Chem. Pharm. Bull., 1994, 42, (6), 1308–1314.
  • Study of design of a microprocessor-based vibrating capillary apparatus to prepare microcap-sules. GHOSAI„ S. K., and PAL, T. K., y. Inst. Eng. (India), Chem. Eng. Div., 1993, 74, 10–12.
  • Incorporation of a perfluoroalkylalkane (RFRH) into the phospholipid bilayer of DMPC liposomes results in greater encapsulation stability. TREVINO, L., FREZARD, F., POSTEL, M., and RIEss, J. G., Y. Liposome Res., 1994, 4, (2), 1017–1028.
  • Enhanced delivery of doxorubicin to the solid tumor by small unilamellar liposomes containing polyethylene glycol. I SHIDA, O., MARUYAMA, K., UNEZAKI, S., TAKAHASHI, N., SUGINAKA, A., and IWATSURU, M., Drug Delivery Syst., 1994, 9, (3), 185–192.
  • Method of microencapsulation of alpha-1,4-glucan-4-glucanohydrolase. WANG, Y., BAI, G., Xi E, P., and ZHANG, H., Mo Kexue Yu jishu, 1993, 13, (4), 40–45.
  • Oral administration of liposomally entrapped tetrahydrobiopterin. SAWADA, Y., SHINTAKU, H., NAKAJIMA, T., IMAMURA, T., TSUBAKIO, Y., IWAMURA, C., ISSHHIKI, G., and OHURA, T., Adv. Exp. Med. Biol., 338, (Chemistry and Biology of Pteridines and Folates), 271–272.
  • Solubility parameter effects on microencapsulation in the presence of polyisobutylene. MOLDENHAUER, M. G., and NAIRN, J. G., y. Controlled Release, 1994, 31, (2), 150–162.
  • Effect of microencapsulated male sterilant .alpha.-chlprohydrin on bait acceptance and antifertility of male Rattus norvegicus. XIAN, X., Eisei Dobutsu, 1994, 45, (1), 33–36.
  • Polylactide microspheres for the controlled release of diazepam. PAVENETTO, F., CONTI, B., GIUNCHEDI, P., GENTA, I., and CONTE, U., Eur. 7. Pharm. Biopharm., 1994, 40, (1), 27–31.
  • Formulation, and in vitro and in vivo evaluation of sustained-release mebeverine hydrochlo-ride microspheres. BAYOMI, M. A., KHIDR, S. H., Arm ELHADY, S. S., and Ai. ANCARY, A. A., Pharm. Ind., 1994, 56, (2), 192–194.
  • Characterization and microencapsulation of enzymic drugs for application as digestion aids in animal nutrition. MAYER, H., and VIERNSTEIN, H.,. Lebensmittelind Milchroirtsch, 1993, 114, (51/52), 1524–1529.
  • Controlled release of styrene-divinylbenzene copolymer microcapsules by phase transform-ation of encapsulated stearic acid. HA'rATE, Y., KASANIATU, K., UgmuRA, Y., IjicHi, K., KAWANO, Y., and YOSHIZAWA, H., J. Chem. Eng. jpn., 1994, 27, (4), 479–484.
  • Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. YERUSHALMI, N., ARAD, A., and MARGAI.IT, R., Arch. Biochem. Biophys., 1994, 313, (2), 267–273.
  • Uptake and biodistribution of free and liposomally incorporated lipopolysaccharide of Aeromonas salmonicida administered via different routes to rainbow trout (Oncorhynchus mykiss). NAKHLA, A. N., SZALAI, A. J., BANOUB, J. H., and KEOUGH, KM. W., J. Liposome Res., 1994, 4, (2), 1029–1048.
  • Anti-hypertensive effect of oral controlled-release microspheres containing an ACE inhibitor (delapril hydrochloride) in rats. AKIYAMA, Y Y0siii0KA, M., HORIBE, H., INADA, Y., FIIRAI, S., KITAMORI, N., and TOGUCHI, H., J. Pharm. Pharmacol., 46, (8), 661–665.
  • Nasal absorption of desmorpressin in rats and sheep. Effect of a bioadhesive microsphere delivery system. CRITCHLEY, H., DAVIS, S. S., FARRAL N. F., and 11.1.um, L., y. Pharm. Pharmacol., 46, (8), 651–656.
  • The influence of surface properties on uptake of oil into complex coacervate microcapsules. RABISKOVA, M., SONG, J., OPAWALE, F. O., and BURGESS, D. J., y. Pharm. Pharmacol., 1994,46, (8), 631–635.
  • Preparation methods of biodegradable microspheres on bovine serum albumin loading efficiency and release profiles. Gm, J. H., Drug Dev. Pharm., 1994, 20, (16), 2535–2545.
  • In vitro release of fluorouracil from albumin microspheres. ZHANG, Z., Lc, N., LIANC;, X., FAN, L., Li, Y., and Li, B., Zhongguo Yiyuan Yaoxue Zazhi, 1994, 14, (5), 197–199.
  • Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG). FLASHER, D., KONOPKA, K., CHAMOW, S. M., DAZIN, P., ASHKENAZI, A., PRETZER, E., and DUEZGUENES, N., Biochim. Biophys. Ada, 1994, 1194, (1), 185–196.
  • Degradation and intrahepatic compatibility of albumin-heparin conjugate microspheres. CREMERS, H. F. M., WOLF, R. F. E., BI.AAUW, E. H., SCHAKENRAAD, J. M., LAM, K. H., NIEUWENHUIS,VERRIJK, R., KWON, G., BAE, Y. H., etal. Biomaterials, 1994,15, (8), 577-585.Calcitonin-loaded liposomes: stability under acidic conditions and bile salts-induced disruption resulting in calcitonin-phospholipid complex formation. ARIEEN, A., HENRY, T. N., and DUPUY, B., Biochim. Biophys. Acta, 1994, 1193, (1), 93–100.
  • Application of REs-avoiding liposomes encapsulated adriamycin for cancer therapy. OKU, N., and Doi, K., Drug Delivery Syst., 1994, 9, (2), 89–95.
  • Transient changes in the mononuclear phagocyte system following administration of the blood substitute liposome-encapsulated hemoglobin. RULDOLPH, A. S., CLIFF, R. O., SPARGO, B. J., and SPIELBERG, H., Biomaterials, 1994, 15, (10), 796–804.
  • Boron delivery by liposomes for BNCT: Development of lipoidal boron compounds. SHELLEY, K., FEAKES, D. A., and HAWTHORNE, M. F., Spec. Publ.-R. Chem., 1994,143, (Current topics in the chemistry of Boron), 1994, 165–168.
  • Long-circulating liposomes. YUDA, T., MARUYAMA, K., TAKIZAWA, T., and IWASTURU, M., Drug Delivery Syst., 1994, 9, (3), 145–160.
  • Evaluation of targeting microsphere drug delivery systems. JIANG, X., and LIAO, G., Huaxi Yaoxue Zazhi, 1993, 8, (2), 99–104.
  • Liposomes for atopic dry skin: the rationale for a promising approach. SCHMID, M. H., and KORTING, H. C., Clin. Invest., 1993, 71, (8), 649–653.
  • Temperature and pH-sensitive liposomes. OZER, A. Y., FARI VAR, M., and HiNcAL, A. A., Eur. J. Pharm. Biopharm., 1993, 39, (3), 97–101.
  • Liposomes from plant phosphatidylcholine. Their production and effects on the skin. GHYCZY, M., GAREISS, J., and KOVATS, T., Cosmet Toiletries, 1994, 109, (7), 75–80.
  • Preparation of liposomes from yeast phospholipids. MATEEV, D. A., BELov, A. P., and MOSICHEV, M. S., Prik. Biokhim. Mikrobiol., 1994, 30, (3), 430–435.
  • Spiral growth in sol-gel YBa2Cu307-delta microspheres. MARELLA, M., MOLINAS, B., BURTET, F. B., MEREGALLI, L., and GERONTOPOULOS, P., J. mate, Sci. Lett., 1994, 13, (15), 1108–1110.
  • Effect of thermal ageing on hardness, tensile and impact properties of a alumina microsphere-reinforced aluminium metal-matrix composite. UNSWORTH, J. P., and BANDYOPADHYAY, S., I. Mater. Sci., 29, (17), 4650-4650.
  • Liposomes in coatings formulations: a new water-borne delivery system. ABATE, K., WALLACH, D. F. H., and CHANG, A. C., Proc. Water-Borne, Higher-Solids, Powder Coat Symp., 1993, 20th, 97–119.
  • Microcelluar microspheres and microballoons by precipitation with a vapor-liquid com-pressed fluid antisolvent. DIXON, D. J., LUNA, B. G., and JOHNSTON, K. P., Polymer, 1994, 35, 3998–4005.
  • Hydrolytic degradation of ionically crosslinked polyphosphazene microspheres. ANDRIANOV, A. K., PAYNE, L. G., VISSCHER, K. B., ALLCOCK, H. R., and LANGER, R., J. App. Polym. Sci., 1994, 53, (12), 1573–1578.
  • Molecular mechanism for the formation process of microspherical structures from heated amino acids. HONDA, H., MAEZAWA, M., IMAI, E., and MATSUNO, K., Viva Origin°, 1994, 22, (2), 71–80.
  • Infrared spectroscopic studies of lyophilized liposomes for characterization of the interaction of free and membrane-bound sugars with phospholipids. NUEIN, P., PFAFF, T., BENDAS, G., WILHELM, F., and CHATTERJEE, S. W., Arch. Pharm. (Weinheim, Ger), 1994, 327, (7), 429–433.
  • A study of complement fixation test by trinitrophenyl-cap-liposome. Application to viral antibody test. YAMAUCHI, T., YAmAmoTo, Y., SAWAYANGI, Y., HUKUSHIMA, M., HIKIZI, K., UEDA, M., and MASAKI, T., Rinsho Byori, 1994, 42 (7), 737–742.
  • Thrombin-induced platelet aggregation in the presence of negatively charged liposomes. ZAKREVSKY, V. I., and KUBATIYEV, A. A., Patol. Fiziol. Eksp. Ter. (1), 19–20.
  • Reconstitution of rat liver gap junctions into liposomes. DIEZ, J. A., and VILLABOLO, A., Biochem. Soc. Trans., 1994, 22, (3), 373S.
  • Solubilization by Triton X-100 makes possible complete recovery of lipids from liposomes in enzymic assay. NAGAYASU, A., SHIMOOKA, T., and KIWADA, H., Biochim. Biophys. Acta, 1994, 1194, (1), 12–16.
  • In vivo fluorescence and photodynamic activity of zinc phthalocyanine administered in liposomes. VAN LEENGOED, H. L. L. M., Cuomo, V., VERSTEEG, A. A. C., VAN DER VEEN N., JoRi, G., and STAR, \V. M., Br. J. Cancer, 1994, 69, (5), 840–845.
  • Enzymic kinetic change of ascorbate oxidase loaded into liposomes induced by microwave fields exposure. RAMUNDO, O. A., ARCOVITO, C., PALOMBO, A., SERAFINO, A. L., and MOSSA, G., J. Liposome Res., 1993, 3, (3), 717–724.
  • Transformation of actin-encapsulating liposomes induced by cytochalasin D. MIYATA, H., KINOSITA, K. JR., Biophys. J., 1994, 67, (2), 922–892.
  • Lipid chain order and dynamics at different bilayer depths in liposomes of several phosphatidylcholines studied by differential polarized phase fluorescence. TRICERRI, M. A., GARDA, H. A., and BRENNER, R. R., Chem. Phys. Lipids., 1994, 71, (1), 61–72.
  • Effect of lanthanide ions on the phase behavior of dipalmitoylphosphatidylcholine multilamel-lar liposomes. Li, X., ZHANG, Y., Ni, J., CHEN, J., and HWANG, F., J. Inorg. Biochem., 1994, 53, (2), 139–149.
  • Biochemical characterization of air-filled albumin microspheres. HELLEBUST, H., CHRIS-TIANSEN, C., and SKOTLAND, T., Biotechnol. Appl. Biochem., 1993, 18, (3), 227–237.
  • Phospholipase-C-promoted liposome fusion. GONI, F. M., NIEVA, J. L., BASANEZ, G., FiDELIO, G., and ALONSO, A., Biochem. Soc. Trans., 1994, 22, (3), 839–844.
  • Transfection of plant protoplasts with tobacco mosaic virus RNA by using electroporation, PEG and cationic liposome-mediated methods. YUAN, T., Wu, J., GONG, Z., YANG, J., and LIN, Q., Shengwu Huaxue Yu Shengwu Wuli Xuebao, 1994, 26, (1), 7–13.
  • Direct plasmid mediated transfection of adult murine brain cells in vivo using cationic liposomes. ROESSLER, B. J., and DAVIDSON, B. L., Neurosci. Lett., 1994, 167, (1-2), 5–10.
  • Effects of liposomes and cations on the local anaesthetic potency of lidocaine. ENDO, Y., ODA, K., and KOKUBU, M., Nippon Shika Masui Gakkai Zasshi, 1994, 22, (2), 260–271.
  • Combination chemotherapy of human ovarian xenografts with intraperitoneal liposome-incorporated valinomycin and cis-diamminedichloroplatinum(II). DAOUD, S. S., Cancer Chemother. Pharmacol., 1994, 33, (4), 307–312.
  • Effect of adriamycin entrapped in sulfatide-containing liposomes on colon tumor cells metastasized to the liver. NAKAHARA, H., YAMAUCHI, M., TAKAGI, H., and YAGI,Clin.Biochem. Nutr., 1994, 16, (2), 115–122.
  • Induction of dog IL-1 by free and liposomal encapsulated doxorubicin. KLAICH, G., and KANTER, P. M., Anti-Cancer Drugs, 1994, 5 (3), 355–360.
  • CGP 55398, a liposomal Ge(IV) phthalocyanine bearing two axially ligated cholesterol moieties. A new potential agent for photodynamic therapy of tumors. SEC:ALLA, A., MILANESI, C., JORI, G., CAPRARO, H. G., ISELE, U., and SCHIEWECK, K., Br. y. Cancer, 1994,69, (5), 817–825.
  • Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous intralipid infusion. WASAN, K. M., GROSSIE, V. B. JR., and LOPEZ, B. G., Antimicrob. Agents Chemother., 1994, 38, (9), 2224–2226.
  • Phagocyte transport as mechanism for enhanced therapeutic activity of liposomal ampho-tericin B. MEHTA, R. T. MCQUEEN, T. J., KEYHANI, A., and LoREz, B. G., Chemotherapy (Basel), 1994, 40, (4), 256–264.
  • Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice. BALLY, M. B., MASIN, D., NAYAR, R., CULLIS, P. R., and MAYER, L. D., Cancer Chemother. Pharmacol., 1994, 34, 137–146.
  • A rapid method for the separation and analysis of leaked and liposomal entrapped phosphoramide mustard in plasma. SRIGRITSANAPOL, A. A., and CHAN, K. K., J. Pharm. Biomed. Anal., 1994, 12, (8), 961–968.
  • Prolongation of cardiac allograft survival in rats by liposome-encapsulated methylpred-nisolone. BINDER, J., MISHINA, E. V., Jusico, W. J., and KUPIEC, W. J. W Transplantation, 1994, 58, (5), 633–635.
  • Leishmaniasis of the tongue treated with liposomal amphotericin B. BAILY, G. G., Purr, M. A., CURRY, A., HABOUBI, N.Y., TurfiN, J. R., and MANDAL, B. K., y. Infect., 1994, 28, (3), 327–331.
  • Fusion of phospholipid vesicles induced by clathrin: modulation of fused liposome size. YOSHIMURA, T., MAEZAWA, S., KAMEYAMA, K., and TAKAGI, T., y. Biochem. (Tokyo), 1994, 115, (4), 715–723.
  • Clinical use of liposomal and lipid-complexed amphotericin B. DE MARIE, S., JANKNEGT, R., and BAKKER, W. I. A., J. Antimicrob. Chemother., 1994, 33, (5), 907–916.
  • Liposomal amphotericin B and continuous venous-venous haemofiltration (letter). HUMPHREYS, H., OLIVER, D. A., WINTER, R., and WARNOCK, D. W., y. Antimicrob. Chemother., 1994, 33, (5), 1070–1071.
  • Antioxidant profile of nimesulide, indomethacin and diclofenac in phosphatidylcholine liposomes (PCL) as membrane model. MAFFEI, F. R., CARINI, M., ALDINI, G., SAIBENE, L., and MACIOCCHI, A., Int. J. Tissue React., 193, 15, (6), 225–234.
  • The immunodominant peptide from listeriolysin in Quil A liposomes vaccinates CD8 + cytolytic T cells and confers protection to infection. LIPFORD, G. B., LEHN, N., BAUER, S., HEEG, K., and WAGNER, H., Immunol. Lett., 1994, 40, (2), 101–104.
  • Study of microencapsulated pituitary transplantation. Preparation of the capsule and its property. CHEN, Z. P., and BAO, Y. D., Chin. Med. J. (Engl), 1994, 107, (3), 200–204.
  • Design of large-scale separation systems for positive and negative immunomagnetic selection of cells using superparamagnetic microspheres. HARDWICK, R. A., KULCINSKI, D., MANSOUR, V., ISHIZAWA, L., LAW, P., and GEE, A. P., J. Hematother, 1992, 1, (4), 379–386.
  • Successful treatment of antimony-resistant cutaneous leishmaniasis with liposomal ampho-tericin B (letter). TORRE, C. J., PRADA, J. L., VILLANUEVA, J. L., VALVERDE, F., and SANCHEZ, G. P., Clin. Infect. Dis., 18, (6), 1024-5.
  • A comparative study of liposome-incorporated beta-lactam antibiotics, fluoroquinolones and cephalosporin conjugates with fluoroquinolones. GRIAZNOVA, N. S., BELIASKAIA, I. V., ZINCHENKO, E., SAZYKIN, J. O., and NAVASHIN, S. M., Antibot. Khimioter., 1993, 38, (12), 3–6.
  • Neoglycosylated liposomes as efficient ligands for the evaluation of specific sugar receptors on macrophages in health and in experimental leishmaniasis. DUTTA, M., BANDYOPADHYAY, R., and BASU, M. K., Parasitology, 1994, 109, (Pt 2), 139–147.
  • Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres. MENEI, P., BENOIT, J. P., BOISDRON, C. M., FOURNIER, D., MERCIER, P., and GUY, G., Neurosurgery, 1994, 34, (6), 1058–1064.
  • Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. VAN ROOHEN, N., and SANDERS, A., J. Immunol. Methods, 1994, 174, (1-2), 83–93.
  • Characterization and kinetics of MHC class 1-restricted presentation of a soluble antigen delivered by liposomes. ZHOU, F., WATKINS, S. C., and HUANG, L., Immunobiology, 1994, 190, (1-2), 35–52.
  • Treatment of neurodermatitis with liposomes? BRAUNINGER, W Dtsch. Med. Wochenschr., 1994, 119, (36), 1219.
  • Phagocyte transport as mechanism for enhanced therapeutic activity of liposomal amphotericin B. MEHTA, R. T., MCQUEEN, T. J., KEYHANI, and A., LOPEZ, B. G., Chemotherapy, 1994, 40, (4), 256–264.
  • Evaluation of the efficacy of praziquantel-liposome against alveococcosis. Li. F. R., JIANG, C. P., CAO, H. X., and WANG, Q., Chung Kuo Chi Chung Hseuh Yu Chi Sheng Chung Ping Tsa Chih, 1993, 11, (4), 251–254.
  • Delivery of cytokines by liposomes. I. Preparation and characterization of interleukin-2 encapsulated in long-circulating sterically stabilized liposomes. KEDAR, E., RUTKOWSKI, Y., BRAUN, E., EMANUEL, N., and BARENHOLZ, Y., J. Immunother. Emphasis Tumor Immunol., 1994, 16, (1), 47–59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.